These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 28647012

  • 1. Striatal Activation Predicts Differential Therapeutic Responses to Methylphenidate and Atomoxetine.
    Schulz KP, Bédard AV, Fan J, Hildebrandt TB, Stein MA, Ivanov I, Halperin JM, Newcorn JH.
    J Am Acad Child Adolesc Psychiatry; 2017 Jul; 56(7):602-609.e2. PubMed ID: 28647012
    [Abstract] [Full Text] [Related]

  • 2. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
    Schulz KP, Fan J, Bédard AC, Clerkin SM, Ivanov I, Tang CY, Halperin JM, Newcorn JH.
    Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
    [Abstract] [Full Text] [Related]

  • 3. Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention-deficit/hyperactivity disorder.
    Bédard AC, Stein MA, Halperin JM, Krone B, Rajwan E, Newcorn JH.
    J Child Psychol Psychiatry; 2015 Jan; 56(1):40-8. PubMed ID: 24942409
    [Abstract] [Full Text] [Related]

  • 4. Methylphenidate and atomoxetine normalise fronto-parietal underactivation during sustained attention in ADHD adolescents.
    Kowalczyk OS, Cubillo AI, Smith A, Barrett N, Giampietro V, Brammer M, Simmons A, Rubia K.
    Eur Neuropsychopharmacol; 2019 Oct; 29(10):1102-1116. PubMed ID: 31358436
    [Abstract] [Full Text] [Related]

  • 5. Osmotic Release Oral System Methylphenidate Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Chinese Youth: 8-Week Comparative Efficacy and 1-Year Follow-Up.
    Su Y, Yang L, Stein MA, Cao Q, Wang Y.
    J Child Adolesc Psychopharmacol; 2016 May; 26(4):362-71. PubMed ID: 26779845
    [Abstract] [Full Text] [Related]

  • 6. Differential long-term medication impact on executive function and delay aversion in ADHD.
    Rubio Morell B, Hernández Expósito S.
    Appl Neuropsychol Child; 2019 May; 8(2):140-157. PubMed ID: 29244542
    [Abstract] [Full Text] [Related]

  • 7. Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats.
    Ruocco LA, Carnevale UA, Treno C, Sadile AG, Melisi D, Arra C, Ibba M, Schirru C, Carboni E.
    Behav Brain Res; 2010 Jun 26; 210(1):99-106. PubMed ID: 20156489
    [Abstract] [Full Text] [Related]

  • 8. Effects of atomoxetine and methylphenidate on sleep in children with ADHD.
    Sangal RB, Owens J, Allen AJ, Sutton V, Schuh K, Kelsey D.
    Sleep; 2006 Dec 26; 29(12):1573-85. PubMed ID: 17252888
    [Abstract] [Full Text] [Related]

  • 9. Differential therapeutic effects of 12-week treatment of atomoxetine and methylphenidate on drug-naïve children with attention deficit/hyperactivity disorder: A counting Stroop functional MRI study.
    Chou TL, Chia S, Shang CY, Gau SS.
    Eur Neuropsychopharmacol; 2015 Dec 26; 25(12):2300-10. PubMed ID: 26409297
    [Abstract] [Full Text] [Related]

  • 10. Prefrontal grey and white matter neurometabolite changes after atomoxetine and methylphenidate in children with attention deficit/hyperactivity disorder: a (1)H magnetic resonance spectroscopy study.
    Husarova V, Bittsansky M, Ondrejka I, Dobrota D.
    Psychiatry Res; 2014 Apr 30; 222(1-2):75-83. PubMed ID: 24679996
    [Abstract] [Full Text] [Related]

  • 11. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
    Wong IC, Asherson P, Bilbow A, Clifford S, Coghill D, DeSoysa R, Hollis C, McCarthy S, Murray M, Planner C, Potts L, Sayal K, Taylor E.
    Health Technol Assess; 2009 Oct 30; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527
    [Abstract] [Full Text] [Related]

  • 12. Single-dose effects of methylphenidate and atomoxetine on functional connectivity during an n-back task in boys with ADHD.
    Kowalczyk OS, Cubillo AI, Criaud M, Giampietro V, O'Daly OG, Mehta MA, Rubia K.
    Psychopharmacology (Berl); 2023 Oct 30; 240(10):2045-2060. PubMed ID: 37500785
    [Abstract] [Full Text] [Related]

  • 13. Differential effects of methylphenidate and atomoxetine on intrinsic brain activity in children with attention deficit hyperactivity disorder.
    Shang CY, Yan CG, Lin HY, Tseng WY, Castellanos FX, Gau SS.
    Psychol Med; 2016 Nov 30; 46(15):3173-3185. PubMed ID: 27574878
    [Abstract] [Full Text] [Related]

  • 14. Shared and drug-specific effects of atomoxetine and methylphenidate on inhibitory brain dysfunction in medication-naive ADHD boys.
    Cubillo A, Smith AB, Barrett N, Giampietro V, Brammer MJ, Simmons A, Rubia K.
    Cereb Cortex; 2014 Jan 30; 24(1):174-85. PubMed ID: 23048018
    [Abstract] [Full Text] [Related]

  • 15. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.
    Volkow ND, Wang GJ, Newcorn J, Telang F, Solanto MV, Fowler JS, Logan J, Ma Y, Schulz K, Pradhan K, Wong C, Swanson JM.
    Arch Gen Psychiatry; 2007 Aug 30; 64(8):932-40. PubMed ID: 17679638
    [Abstract] [Full Text] [Related]

  • 16. Anxiety reduction on atomoxetine and methylphenidate medication in children with ADHD.
    Snircova E, Marcincakova-Husarova V, Hrtanek I, Kulhan T, Ondrejka I, Nosalova G.
    Pediatr Int; 2016 Jun 30; 58(6):476-81. PubMed ID: 26579704
    [Abstract] [Full Text] [Related]

  • 17. Cost of ADHD treatment using methylphenidate and atomoxetine in the South African private healthcare sector.
    Munasur-Naidoo AP, Truter I.
    Expert Rev Pharmacoecon Outcomes Res; 2019 Dec 30; 19(6):677-684. PubMed ID: 31456453
    [Abstract] [Full Text] [Related]

  • 18. Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.
    Newcorn JH, Kratochvil CJ, Allen AJ, Casat CD, Ruff DD, Moore RJ, Michelson D, Atomoxetine/Methylphenidate Comparative Study Group.
    Am J Psychiatry; 2008 Jun 30; 165(6):721-30. PubMed ID: 18281409
    [Abstract] [Full Text] [Related]

  • 19. Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task.
    Bush G, Spencer TJ, Holmes J, Shin LM, Valera EM, Seidman LJ, Makris N, Surman C, Aleardi M, Mick E, Biederman J.
    Arch Gen Psychiatry; 2008 Jan 30; 65(1):102-14. PubMed ID: 18180434
    [Abstract] [Full Text] [Related]

  • 20. Age-related changes in prefrontal norepinephrine transporter density: The basis for improved cognitive flexibility after low doses of atomoxetine in adolescent rats.
    Bradshaw SE, Agster KL, Waterhouse BD, McGaughy JA.
    Brain Res; 2016 Jun 15; 1641(Pt B):245-57. PubMed ID: 26774596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.